Abn Uterine Bleeding Flashcards
What should always be ruled out?
Pregnancy
Eval of AUB depends on what?
Age and RF of patient
Normal Menstral bleeding
Avg of 5 days with a mean loss of 40ml per cycle
Menorrhagia
blood loss of >80ml per cycle and often produces anemia
Metrorrhagia
Bleeding between periods
Polymenorrhea
Bleeding that happens more often than eery 21 days
Oligomenorrhea
Bleeding that occurs less frequently than every 35 days
PALM COEIN
Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia, Coagulaopathy, Ovulatory dysfunction, Endometrial, iatrogenic, not yet classified
Descriptive terms for bleeding pattern
heavy, light, menstrual or intramenstrual
Adolescents with AUB
result of persistent anovulation due to immaturity of hypothalamic- pituitary- ovarian axis and represents normal physiology. Once regular menses occurs during adolescence- Ovulatory dysfunction AUB (AUB-O) accounts for most cases.
AUB Woman btw 19-39
pregnancy, structural lesions, anovulatory cycles, use of hormonal contraception, or endometrial hyperplasia
Lab studies
CBC, Preg test, thyroid studies
Coagulation study should be considered
Vaginal/Urine samples to r/o chlamydia
Diagnostic Imaging
Transvaginal US- dx intrauterine/ectopic pregnancy, adnexal/uterine masses, evaluate endometrial thickness
Sonohystergraphy or hysterocopy- endometrial polyps or subserous myomas
MRI- definitively diagnose submucous myomas and adenomyosis
Cervical Biopsy and Endometrial Sampling
determines if hyperplasia or carcinoma is present
Endometrial Sampling
perform in patients with AUB who are older than 45 or in younger patients with hx of unopposed estrogen exposure or failed management/persistent AUB to identify polyps, endometrial hyperplasia and submucous myomas
Premenopausal + Ovulatory dysfunction AUB
irregular or light bleeding
medroxyprogesterone actate 10mg/day or norethindrone acetate 5mg/day, should be given for 10 days, following which withdrawal bleeding can occur, if works can be repeated for several cycles, starting on day 15 of following cycles. Can be reinstitute if amenorrhea or dysfunctional bleeding recurs
Premenopausal + Ovulatory dysfunction AUB
Menorrhagia
NSAIDS- Naproxen or mefenamic acid- reduce blood even that associated with a copper IUD
Premenopausal + Ovulatory dysfunction AUB
heavier bleeding
taper of any COC with 30-35mcg of estrogen estradiol to control the bleeding,
several regimens- 4x a day for 1-2 days then 2 pills daily through day 5 then one pill a day through day 20, after withdrawal bleeding occurs pills are taken usual dosage for 3 cycles
Premenopausal + Ovulatory dysfunction AUB
Intractable Heavy Bleeding
GnHR agonist (depor leuprolide, 3.75mg IM every month) for up to 6 months to create temporary cessation of menstruation by ovarian suppression. require 2-4 weeks to down-regulate the pituitary and stop the bleeding. Will not sop bleeding acutely
Premenopausal + Ovulatory dysfunction AUB
Heavy bleeding requiring hospitalization
IV conjugated estrogen 25mg Q4hrx 3-4 doses followed by oral conjugated estrogsten 2.5mg daily or eithunyl estradiol 20mcg orally daily for 3 weeks.
ABN bleeding uncontrolled with hormones
hysterocopy with tissues sampling or saline infusion sonohysterography is used to evaluate for structural lesions or neoplasms
Bleeding unresponsive to medical therapy- after all causes have been ruled out
endometrial ablation- LNG-IUD- markedly reduces menstrual blood loss- good alternative to other therapies or hysterectomy
When to refer-
bleeding not controlled with 1st line medication or expertise required for sx procedure
when to admit
bleeding uncontrolled with 1st line or patient is not hemodynamically stable
Anovulatory AUB/DUB
irregular cycle, short cycles with scanty flow or period of amenorrhea